{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/asthma/prescribing-information/inhaled-corticosteroids/","result":{"pageContext":{"chapter":{"id":"dc8f7545-ff7a-5bf1-8ac8-95161137fac5","slug":"inhaled-corticosteroids","fullItemName":"Inhaled corticosteroids","depth":2,"htmlHeader":"<!-- begin field 749ec473-1ed5-4f2f-a593-a6d7016a940e --><h2>Inhaled corticosteroids</h2><!-- end field 749ec473-1ed5-4f2f-a593-a6d7016a940e -->","summary":"","htmlStringContent":"<!-- begin item 2941a4c0-4c3b-40cd-8090-a6d7016a8eeb --><!-- begin field e29ad118-38c1-4b2d-83e9-a6d7016a940e --><ul><li><strong>Inhaled corticosteroids (ICS) used in the treatment of asthma include beclometasone, budesonide, ciclesonide, fluticasone, and mometasone.</strong><ul><li>Note: for detailed prescribing information on inhaled corticosteroids, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-inhaled/\">Corticosteroids - inhaled</a>.</li></ul></li><li>Consider issuing a steroid treatment card [<a class=\"bibliography-reference internal-reference\" href=\"/topics/asthma/references/\">MHRA, 2006</a>] to:<ul><li>People using prolonged high doses of inhaled corticosteroids.</li><li>People taking inhaled corticosteroids plus drugs that inhibit their metabolism (for example cytochrome P450 inhibitors, such as HIV protease inhibitors).</li></ul></li><li>ICS can be given via a pressurized metered dose inhaler (PMDI) or a dry powder inhaler (DPI). For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/asthma/management/newly-diagnosed-asthma/#delivery-systems\">delivery systems</a>. </li><li>Combination inhalers which deliver an ICS in combination with a long-acting beta-2 agonist (LABA) are also available.</li><li><strong>Use the lowest dose of inhaled corticosteroid (ICS) that maintains effective control of asthma and start ICS at a dose appropriate to the severity of symptoms.</strong> For more information, see the section <a class=\"topic-reference internal-reference\" href=\"/topics/asthma/management/newly-diagnosed-asthma/\">How should I manage someone with newly-diagnosed asthma?</a>.</li><li><strong>NICE has have issued the following guidance on ICS dosages for adults aged 17 and over:</strong><ul><li>More than 800 micrograms budesonide or equivalent would be considered a high dose.</li><li>More than 400 micrograms to 800 micrograms budesonide or equivalent would be considered a moderate dose.</li><li>Less than or equal to 400 micrograms budesonide or equivalent would be considered a low dose.<ul><li>Note: BTS/SIGN use the same terminology as NICE to define these three dosage categories for adults, as in table 1 below.</li></ul></li></ul></li><li><strong>NICE has issued the following guidance on ICS dosages for children and young people aged 16 and under:</strong><ul><li>Less than or equal to 200 micrograms budesonide or equivalent would be considered a paediatric low dose (Note: BTS/SIGN classify this dose range as 'very low dose', as in table 2 below).</li><li>More than 200 micrograms to 400 micrograms budesonide or equivalent would be considered a paediatric moderate dose (Note: BTS/SIGN classify this dose range as 'low dose' as in table 2 below).</li><li>More than 400 micrograms budesonide or equivalent would be considered a paediatric high dose (Note: BTS/SIGN classify this dose range as 'medium dose' as in table 2 below).</li></ul></li><li><strong>For information about dose equivalance between different steroid preparations, please see tables 1 and 2 below.</strong></li></ul><p><strong>Table 1.</strong> Categorization of inhaled corticosteroids by dose in adults (N.B. different products are licensed for different age groups and some may also be applicable to older children. Before prescribing, consult the manufacturer's summary of product characteristics) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/asthma/references/\">BTS/SIGN, 2019</a>].</p><table data-table-id=\"a43abedf-f54b-40f6-b83a-acce00f768fe\"><thead><tr><th scope=\"col\"> </th><th scope=\"col\">Low dose</th><th scope=\"col\">Medium dose</th><th scope=\"col\">High dose </th></tr></thead><tbody><tr><td colspan=\"4\"><strong>Pressurized metered dose inhalers</strong></td></tr><tr><td colspan=\"4\">Beclometasone dipropionate</td></tr><tr><td>Non-proprietary</td><td>100 micrograms, two puffs twice a day</td><td>200 micrograms, two puffs twice a day</td><td>200 micrograms, four puffs twice a day</td></tr><tr><td>Clenil Modulite </td><td>100 micrograms, two puffs twice a day</td><td>200 micrograms, two puffs twice a day</td><td><p>250 micrograms, two puffs twice a day, <em>or</em></p><p>250 micrograms, four puffs twice a day</p></td></tr><tr><td>Kelhale (extrafine)</td><td>50 micrograms, two puffs twice a day</td><td>100 micrograms, two puffs twice a day</td><td>100 micrograms, four puffs twice a day</td></tr><tr><td><p>Qvar (extrafine)</p><p>Qvar autohaler</p><p>Qvar Easi-breathe</p></td><td>50 micrograms, two puffs twice a day</td><td>100 micrograms, two puffs twice a day</td><td>100 micrograms, four puffs twice a day</td></tr><tr><td>Soprobec</td><td>100 micrograms, two puffs twice daily</td><td>200 micrograms, two puffs twice a day</td><td><p>250 micrograms, two puffs twice a day, <em>or</em></p><p>250 micrograms, four puffs twice a day</p></td></tr><tr><td colspan=\"4\">Ciclesonide</td></tr><tr><td>Alvesco </td><td>80 micrograms, two puffs once a day</td><td>160 micrograms, two puffs once a day</td><td>160 micrograms, two puffs twice a day </td></tr><tr><td colspan=\"4\">Fluticasone propionate</td></tr><tr><td>Flixotide Evohaler</td><td>50 micrograms, two puffs twice a day</td><td>125 micrograms, two puffs twice a day</td><td>250 micrograms, two puffs twice a day</td></tr><tr><td colspan=\"4\"><strong>Dry powder inhalers</strong></td></tr><tr><td colspan=\"4\">Beclometasone</td></tr><tr><td>Non-proprietary Easyhaler</td><td>200 micrograms, one puff twice a day</td><td>200 micrograms, two puffs twice a day</td><td> </td></tr><tr><td>Asmabec</td><td>100 micrograms, one puff twice a day</td><td>100 micrograms, two puffs twice a day</td><td> </td></tr><tr><td colspan=\"4\">Budesonide</td></tr><tr><td>Non-proprietary Easyhaler</td><td>100 micrograms, two puffs twice a day</td><td>200 micrograms, two puffs twice a day</td><td>400 micrograms, two puffs twice a day</td></tr><tr><td>Budelin Novolizer</td><td> </td><td>200 micrograms, two puffs twice a day</td><td>200 micrograms, four puffs twice a day</td></tr><tr><td>Pulmicort Turbohaler</td><td><p>100 micrograms, two puffs twice a day, <em>or</em></p><p>200 micrograms, one puff twice a day</p></td><td><p>200 micrograms, two puffs twice a day, <em>or</em></p><p>400 micrograms, one puff twice a day</p></td><td>400 micrograms, two puffs twice a day</td></tr><tr><td colspan=\"4\">Fluticasone propionate</td></tr><tr><td>Flixotide Accuhaler</td><td>100 micrograms, one puff twice a day</td><td>250 micrograms, one puff twice a day</td><td>500 micrograms, one puff twice a day</td></tr><tr><td colspan=\"4\">Mometasone</td></tr><tr><td>Asmanex Twisthaler</td><td>200 micrograms, one puff twice a day</td><td>400 micrograms, one puff twice a day</td><td> </td></tr><tr><td colspan=\"4\"><strong>Combination inhalers</strong></td></tr><tr><td colspan=\"4\">Beclometasone dipropionate (extrafine) with formoterol</td></tr><tr><td>Fostair (pMDI)</td><td>100/6, one puff twice a day</td><td>100/6, two puffs twice a day</td><td>200/6, two puffs twice a day</td></tr><tr><td>Fostair (NEXThaler)</td><td>100/6, one puff twice a day</td><td>100/6, two puffs twice a day</td><td>200/6, two puffs twice a day</td></tr><tr><td colspan=\"4\">Budesonide with formoterol</td></tr><tr><td>DuoResp Spiromax</td><td>160/4.5, one puff twice a day</td><td><p>160/4.5, two puffs twice a day, <em>or</em></p><p>320/9, one puff twice a day</p></td><td>320/9, two puffs twice a day</td></tr><tr><td>Symbicort Turbohaler</td><td><p>100/6, two puffs twice a day, <em>or</em></p><p>200/6, one puff twice a day</p></td><td><p>200/6, two puffs twice a day, <em>or</em></p><p>400/12, one puff twice a day</p></td><td>400/12, two puffs twice a day</td></tr><tr><td>Fobumix Easyhaler</td><td><p>80/4.5, two puffs twice a day, <em>or </em></p><p>160/4.5, one puff twice a day</p></td><td><p>160/4.5, two puffs twice a day, <em>or</em></p><p>320/9, one puff twice a day</p></td><td>320/9, two puffs twice daily</td></tr><tr><td colspan=\"4\">Fluticasone propionate with formoterol</td></tr><tr><td>Flutiform</td><td>50/5, two puffs twice a day</td><td>125/5, two puffs twice a day</td><td>250/10, two puffs twice a day</td></tr><tr><td>Flutiform K-haler</td><td>50/5, two puffs twice a day</td><td>125/5, two puffs twice a day</td><td> </td></tr><tr><td colspan=\"4\">Fluticasone propionate with salmeterol</td></tr><tr><td>Aerivio Spiromax</td><td> </td><td> </td><td>500/50, one puff twice a day</td></tr><tr><td>AirFluSal Forspiro</td><td> </td><td> </td><td>500/50, one puff twice a day</td></tr><tr><td>AirFluSal (pMDI)</td><td> </td><td>125/25, two puffs twice a day</td><td>250/25, two puffs twice a day</td></tr><tr><td>Aloflute (pMDI)</td><td> </td><td>125/25, two puffs twice a day</td><td>250/25, two puffs twice a day</td></tr><tr><td>Combisal (pMDI)</td><td>50/25, two puffs twice a day</td><td>125/25, two puffs twice a day</td><td>250/25, two puffs twice a day</td></tr><tr><td>Fusacomb Easyhaler</td><td> </td><td>250/50, one puff twice a day</td><td>500/50, one puff twice a day</td></tr><tr><td>Sereflo (pMDI)</td><td> </td><td>125/25, two puffs twice a day</td><td>250/25, two puffs twice a day</td></tr><tr><td>Seretide Accuhaler</td><td>100/50, one puff twice a day</td><td>250/50, one puff twice a day</td><td>500/50 one puff twice a day</td></tr><tr><td>Seretide Evohaler</td><td>50/25, two puffs twice a day</td><td>125/25, two puffs twice a day</td><td>250/25, two puffs twice a day</td></tr><tr><td>Sirdupla (pMDI)</td><td> </td><td>125/25, two puffs twice a day</td><td>250/25, two puffs twice a day</td></tr><tr><td>Stalpex Orbicel</td><td> </td><td> </td><td>500/50, one puff once a day</td></tr><tr><td colspan=\"4\">Fluticasone furoate with vilanterol</td></tr><tr><td>Relvar Ellipta</td><td> </td><td>92/22, one puff once a day</td><td>184/22, one puff once a day</td></tr></tbody></table><p><strong>Table 2. </strong>Categorization of inhaled corticosteroids by dose in children (N.B. different products are licensed for different age groups. Before prescribing, consult the manufacturer's summary of product characteristics) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/asthma/references/\">BTS/SIGN, 2019</a>].</p><table data-table-id=\"23684944-7e5f-4470-8829-acce00f768ff\"><thead><tr><th scope=\"col\"> </th><th scope=\"col\">Very low dose</th><th scope=\"col\">Low dose</th><th scope=\"col\">Medium dose </th></tr></thead><tbody><tr><td colspan=\"4\"><strong>Pressurized metered dose inhalers</strong></td></tr><tr><td colspan=\"4\">Beclometasone dipropionate</td></tr><tr><td>Non-proprietary</td><td>50 micrograms, two puffs twice a day</td><td>100 micrograms, two puffs twice a day</td><td>200 micrograms, two puffs twice a day</td></tr><tr><td>Clenil Modulite </td><td>50 micrograms, two puffs twice a day</td><td>100 micrograms, two puffs twice a day</td><td><p>200 micrograms, two puffs twice a day</p></td></tr><tr><td><p>Qvar (extrafine)</p><p>Qvar autohaler</p><p>Qvar Easi-breathe</p></td><td> </td><td>50 micrograms, two puffs twice a day</td><td>100 micrograms, two puffs twice a day</td></tr><tr><td>Soprobec</td><td>50 micrograms, two puffs twice a day</td><td>100 micrograms, two puffs twice a day</td><td>200 micrograms, two puffs twice a day</td></tr><tr><td colspan=\"4\">Ciclesonide</td></tr><tr><td>Alvesco Aerosol inhaler</td><td> </td><td>80 micrograms, two puffs once a day</td><td>160 micrograms, two puffs once a day</td></tr><tr><td colspan=\"4\">Fluticasone propionate</td></tr><tr><td>Flixotide Evohaler</td><td>50 micrograms, one puff twice a day</td><td>50 micrograms, two puffs twice a day</td><td>125 micrograms, two puffs twice a day</td></tr><tr><td colspan=\"4\"><strong>Dry powder inhalers</strong></td></tr><tr><td colspan=\"4\">Budesonide</td></tr><tr><td>Non-proprietary Easyhaler</td><td> </td><td>100 micrograms, two puffs twice a day</td><td>200 micrograms, two puffs twice a day</td></tr><tr><td>Pulmicort Turbohaler</td><td>100 micrograms, one puff twice a day</td><td><p>100 micrograms, two puffs twice a day, <em>or</em></p><p>200 micrograms, one puff twice a day</p></td><td>200 micrograms, two puffs twice a day, <em>or</em><br>400 micrograms, one puff twice a day</td></tr><tr><td colspan=\"4\">Fluticasone propionate</td></tr><tr><td>Flixotide Accuhaler</td><td>50 micrograms, one puff twice a day</td><td>100 micrograms, one puff twice a day</td><td>250 micrograms, one puff twice a day</td></tr><tr><td colspan=\"4\">Mometasone</td></tr><tr><td>Asmanex Twisthaler</td><td> </td><td>200 micrograms, one puff twice a day</td><td> </td></tr><tr><td colspan=\"4\"><strong>Combination inhalers</strong></td></tr><tr><td colspan=\"4\">Budesonide with formoterol</td></tr><tr><td>Symbicort Turbohaler</td><td><p>100/6, one puff twice a day </p></td><td><p>100/6, two puffs twice a day, <em>or</em></p><p>200/6, one puff twice a day</p></td><td> </td></tr><tr><td colspan=\"4\">Fluticasone propionate with salmeterol</td></tr><tr><td>Combisal (pMDI)</td><td> </td><td>50/25, two puffs twice a day</td><td> </td></tr><tr><td>Seretide Accuhaler</td><td> </td><td>100/50, one puff twice a day</td><td> </td></tr><tr><td>Seretide Evohaler</td><td> </td><td>50/25, two puffs twice a day</td><td> </td></tr></tbody></table><!-- end field e29ad118-38c1-4b2d-83e9-a6d7016a940e --><!-- end item 2941a4c0-4c3b-40cd-8090-a6d7016a8eeb -->","topic":{"id":"d631356f-d3a3-51fb-807c-5517c470a5af","topicId":"2a0a90e6-1c4e-4b6a-9ce2-3379dd122594","topicName":"Asthma","slug":"asthma","lastRevised":"Last revised in October 2020","chapters":[{"id":"c7185669-75fd-5c6e-b105-63a3237634ac","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9fe1ab10-4b4d-5ba8-9ef0-00631cd00ea4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"770d55df-2c61-5d1e-83d9-92b12ccae96a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d2031db2-44fd-55bb-b5c8-d085b387747a","slug":"changes","fullItemName":"Changes"},{"id":"a993bde1-1ac8-529e-8a3e-201a8c082ab2","slug":"update","fullItemName":"Update"}]},{"id":"eae8fe92-3941-512e-bcc6-f1e15157c1ae","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8e125759-cd9d-510d-9659-3c2e77baa755","slug":"goals","fullItemName":"Goals"},{"id":"a6c91cd5-1ce2-5c60-86cc-341a9dccf3d4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a5746054-2f36-5a42-9e7c-7af9107ad99b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5fd19cd9-6ac7-54c8-89be-817d58e41309","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f7339086-c653-53dd-990c-6d470fa223b8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f43b79db-3c62-58ee-bb70-932e6613eea6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0d12a387-5436-5c75-92c0-189cb391ec7a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8fbe04ed-5fd7-54c9-be84-6c959f75af3b","slug":"definition","fullItemName":"Definition"},{"id":"5cbe6206-f80c-5a71-8e4d-a4d44e392874","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2fb588ab-6181-5aec-8a4a-fb368098329d","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b786654f-5e6e-5e5f-9ead-abaca7f99ba5","slug":"prognosis","fullItemName":"Prognosis"},{"id":"c0b65c0b-957e-538e-83e9-5b4af2d8e6dd","slug":"complications","fullItemName":"Complications"}]},{"id":"574c6193-f36f-5bf7-946a-d8c688476131","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"351773e5-286c-5560-8402-79c2d92d4aa6","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"053272da-fea9-5df6-842a-0de682896aaf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"7b632c20-012f-590e-a01e-cda5715d6f14","fullItemName":"Management","slug":"management","subChapters":[{"id":"f95fb73f-b749-53a5-b857-4d2bb9945667","slug":"newly-diagnosed-asthma","fullItemName":"Scenario: Newly-diagnosed asthma"},{"id":"2878c5f8-3e3f-52c8-a9bd-7988906b6f99","slug":"follow-up","fullItemName":"Scenario: Follow-up"},{"id":"2458c073-8efb-5a81-8bc4-9a543deab17d","slug":"acute-exacerbation-of-asthma","fullItemName":"Scenario: Acute exacerbation of asthma"},{"id":"45a1b06c-1e5d-56b4-8da7-a8abf4f6c7cc","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"fb9dc424-4306-54a1-b06b-1b01273ac473","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"52940123-8084-55c3-b593-cc9fe50daf8f","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"5eb1288c-29af-59c1-b623-bd0010732835","slug":"beta-2-agonists","fullItemName":"Beta-2 agonists"},{"id":"dc8f7545-ff7a-5bf1-8ac8-95161137fac5","slug":"inhaled-corticosteroids","fullItemName":"Inhaled corticosteroids"},{"id":"4d715496-c821-52e3-8ea0-d05cfb33d3eb","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"},{"id":"d8174f33-d787-5076-88b5-f4c67df93128","slug":"leukotriene-receptor-antagonists","fullItemName":"Leukotriene receptor antagonists"},{"id":"a556cd4f-1851-52fd-a993-34e977a27fd2","slug":"muscarinic-agents","fullItemName":"Muscarinic agents"},{"id":"0cea3b69-b77b-505e-bded-6fceaca145df","slug":"theophylline","fullItemName":"Theophylline"},{"id":"550429f1-7cab-5f16-b476-e479d8084c03","slug":"cromones","fullItemName":"Cromones"}]},{"id":"76b3dfce-ba54-5456-a259-79b345a5e064","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e31b3681-17cc-5ff2-ba28-d3b1fcb0a82c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2bcf3eeb-fd2e-5d40-a52f-da626afbbe01","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"14ea4312-4846-5381-a82c-dc6b03a60d04","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e4987bc8-0a78-59eb-bfda-f9de7c9ee182","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"be4f3045-8192-53b7-81a3-b460bb2218bc","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"82ae443c-942c-5053-a988-38bce8dec570","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"efdf3cf8-dee5-5351-9d2d-346b4fdf9faf","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"fb9dc424-4306-54a1-b06b-1b01273ac473","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}